ibrutinib
janssen,abbvie
['mantle,(-dismantle)', 'ibru', 'lymphoma']
the largest trial to date in mantle cell lymphoma shows that adding the btk inhibitor #ibrutinib to soc treatment improves pfs by 50%. #asco22 \
The leading online provider of #CME, #CNE, #CE, and #CPE across 30+ medical specialties to support health professionals in improving patient care.